Fig. 1
From: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma
Survival probability of MM patients of H12O cohort. A Global cohort. B Patients < 65 years. C Patients 65–75 years. D Patients > 75 years
Fig. 1 | Journal of Hematology & Oncology